Kaiser, I.; Kauertz, K.; Zöllner, S.K.; Hartmann, W.; Langer, T.; Jürgens, H.; Ranft, A.; Dirksen, U.
Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers 2022, 14, 5920.
https://doi.org/10.3390/cancers14235920
AMA Style
Kaiser I, Kauertz K, Zöllner SK, Hartmann W, Langer T, Jürgens H, Ranft A, Dirksen U.
Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers. 2022; 14(23):5920.
https://doi.org/10.3390/cancers14235920
Chicago/Turabian Style
Kaiser, Isabelle, Katja Kauertz, Stefan K. Zöllner, Wolfgang Hartmann, Thorsten Langer, Heribert Jürgens, Andreas Ranft, and Uta Dirksen.
2022. "Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry" Cancers 14, no. 23: 5920.
https://doi.org/10.3390/cancers14235920
APA Style
Kaiser, I., Kauertz, K., Zöllner, S. K., Hartmann, W., Langer, T., Jürgens, H., Ranft, A., & Dirksen, U.
(2022). Secondary Malignancies after Ewing Sarcoma—Epidemiological and Clinical Analysis of an International Trial Registry. Cancers, 14(23), 5920.
https://doi.org/10.3390/cancers14235920